Latest news:
CytoReason to license IBD Disease Model to Sanof in Multiyear, Multimillion sign dollar deal!
THE CYTOREASON DISEASE MODEL
Think of it as the most comprehensive model of human diseases.
Modeling and comparing treatments and patient groups so you get a clear map of disease and drug mechanisms.
MANAGE YOUR DRUG PORTFOLIO
Prioritize all of your programs, compare your treatments to competing treatments, and your drugs across patient populations.
MANAGE YOUR DRUG PORTFOLIO
Prioritize all of your programs, compare your treatments to competing treatments, and your drugs across patient populations.
SEE THE FOREST AND THE TREES
Give your scientist a deep profile of your drug, and your executive a bird’s-eye view of your entire portfolio. One platform for all users.
SEE THE FOREST AND THE TREES
Give your scientist a deep profile of your drug, and your executive a bird’s-eye view of your entire portfolio. One platform for all users.
LISTEN TO LIVING DATA
Base your decisions on the latest human data as your disease models are updated. Use live results to make accurate predictions.
LISTEN TO LIVING DATA
Base your decisions on the latest human data as your disease models are updated. Use live results to make accurate predictions.
KNOW THE RISK AHEAD
Connect molecular mechanisms to your drug’s performance and compare to other drugs in the market. Follow early signals and gain long-term confidence.
KNOW THE RISK AHEAD
Connect molecular mechanisms to your drug’s performance and compare to other drugs in the market. Follow early signals and gain long-term confidence.
In the news
''
The difference between using CytoReason technology and not using it, is the difference between engineering and art.
''
Mike Vincent
SVP Immunology & Inflammation
